Jacob Chacko Oric Pharmaceuticals, Inc. (ORIC) insider trading activity

Jacob Chacko is PRESIDENT AND CEO of Oric Pharmaceuticals, Inc.. Currently has a direct ownership of 581,711 shares of ORIC, which is worth approximately $7.61 Million. The most recent transaction as insider was on Dec 16, 2025, when has been sold 33,374 shares (Common Stock) at a price of $9.06 per share, resulting in proceeds of $302,368. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 582K

9.46% 3M change

25.29% 12M change

Total Value Held $7.61 Million

Jacob Chacko Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2025	SELL Open market or private sale	$302,368 $9.06 p/Share	33,374 Reduced 5.43%	581,711 Common Stock
Dec 15 2025	BUY Exercise of conversion of derivative security	-	83,666 Added 11.97%	615,085 Common Stock
Oct 06 2025	SELL Open market or private sale	$461,519 $12.32 p/Share	37,461 Reduced 6.59%	531,419 Common Stock
Oct 01 2025	SELL Open market or private sale	$638,662 $12.05 p/Share	53,001 Reduced 8.52%	568,880 Common Stock
Sep 30 2025	SELL Open market or private sale	$414,801 $12.01 p/Share	34,538 Reduced 5.26%	621,881 Common Stock
Sep 22 2025	SELL Open market or private sale	$1,350,000 $10.8 p/Share	125,000 Reduced 16.0%	656,419 Common Stock
Dec 16 2024	SELL Open market or private sale	$204,184 $8.28 p/Share	24,660 Reduced 3.07%	778,648 Common Stock

Dec 15 2024	BUY Exercise of conversion of derivative security	-	67,000 Added 7.7%	803,308 Common Stock
Mar 06 2024	SELL Open market or private sale	$648,400 $16.21 p/Share	40,000 Reduced 5.2%	728,544 Common Stock
Feb 07 2024	SELL Open market or private sale	$320,056 $12.29 p/Share	26,042 Reduced 3.28%	768,544 Common Stock
Feb 06 2024	SELL Open market or private sale	$169,170 $12.12 p/Share	13,958 Reduced 1.73%	794,586 Common Stock
Dec 15 2023	SELL Open market or private sale	$124,744 $8.58 p/Share	14,539 Reduced 1.77%	808,544 Common Stock
Dec 15 2023	BUY Exercise of conversion of derivative security	-	38,667 Added 4.49%	823,083 Common Stock
Jul 11 2023	SELL Open market or private sale	$41,299 $8.01 p/Share	5,156 Reduced 0.66%	780,652 Common Stock
Jul 10 2023	SELL Open market or private sale	$84,169 $8.01 p/Share	10,508 Reduced 1.32%	785,808 Common Stock
Jul 05 2023	SELL Open market or private sale	$34,731 $8.01 p/Share	4,336 Reduced 0.54%	796,316 Common Stock
Jun 26 2023	SELL Open market or private sale	$160,600 $8.03 p/Share	20,000 Reduced 2.44%	800,652 Common Stock
Dec 15 2022	SELL Open market or private sale	$18,733 $3.25 p/Share	5,764 Reduced 0.7%	817,025 Common Stock
Dec 15 2022	BUY Exercise of conversion of derivative security	-	16,666 Added 1.99%	822,789 Common Stock
May 13 2022	BUY Open market or private purchase	$214,523 $2.82 p/Share	76,072 Added 8.66%	802,652 Common Stock
May 12 2022	BUY Open market or private purchase	$190,724 $2.75 p/Share	69,354 Added 8.71%	726,580 Common Stock
May 11 2022	BUY Open market or private purchase	$883,265 $2.9 p/Share	304,574 Added 31.67%	657,226 Common Stock
Mar 25 2022	BUY Open market or private purchase	$227,000 $4.54 p/Share	50,000 Added 12.42%	352,652 Common Stock
Mar 24 2022	BUY Open market or private purchase	$215,651 $5.03 p/Share	42,873 Added 12.41%	302,652 Common Stock
Mar 23 2022	BUY Open market or private purchase	$1,280,492 $4.98 p/Share	257,127 Added 49.74%	259,779 Common Stock

Also insider at

TPTX

Turning Point Therapeutics, Inc.

Director

FDMT

4D Molecular Therapeutics, Inc. Healthcare

Jacob Chacko

PRESIDENT AND CEO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORIC shares.

Notify only if

Value

Insider Trading

Get notified when an Oric Pharmaceuticals, Inc. insider buys or sells ORIC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Oric Pharmaceuticals, Inc.

Track Activities on ORIC

Account